Physicians at Memorial Sloan-Kettering have developed a tool, known as a nomogram, to help predict length of survival for patients with pancreatic cancer.
The pancreatic cancer nomogram is intended for use by physicians and other treatment specialists who are treating adult patients with resected adenocarcinoma of the pancreas.
The nomogram uses a combination of factors, including margin of resection, location of lesion, and maximum path axis, to define and predict treatment outcome.
Although this nomogram is intended to give patients an expectation of treatment outcome, no nomogram can give absolute predictions. Physicians should interpret these results alongside a patient’s complete medical history.
Having an accurate understanding a patient’s prognosis is important in evaluating treatment options for patients with pancreatic cancer.
In order for this nomogram to provide an accurate prediction, you will need to include accurate values for all of the information below.
If you have questions or comments, please contact us at nomograms@mskcc.org.